Singapore Explores Agentic AI Applications in Healthcare Amid National AI Expansion
Advertisement
Announced by the Ministry of Health in October, the funding is intended to drive system-wide implementation of AI-powered solutions and strengthen digital healthcare capabilities.
Singapore is exploring the use of agentic artificial intelligence (AI) in healthcare as it accelerates the adoption of advanced AI technologies across its public health system, according to the country’s national health technology agency, Synapxe.
The move follows the Singapore government’s commitment of SG$200 million (approximately $150 million) over five years to support the deployment of AI technologies in healthcare. Announced by the Ministry of Health in October, the funding is intended to drive system-wide implementation of AI-powered solutions and strengthen digital healthcare capabilities.
A key focus of the initiative is the adoption of generative AI tools to automate administrative and documentation tasks. The government aims to introduce a generative AI-powered solution capable of automating updates to health records by the end of 2025, reducing the administrative burden on healthcare professionals.
To support AI adoption, Synapxe has launched several initiatives, including GenAIus Hub, a learning repository designed to improve understanding of generative AI among healthcare workers. The agency has also introduced Synapxe Tandem, a platform that provides prompt templates and a secure environment for healthcare professionals to test and evaluate generative AI applications at scale.
According to Andy Ta, chief data officer and director of Data Analytics and AI at Synapxe, the agency is focused on helping healthcare institutions overcome barriers to AI adoption by providing access to tools, training, and testing platforms. Synapxe is also organizing competitions that encourage healthcare practitioners to apply generative AI to real-world clinical and operational challenges while developing skills in large language model deployment.
Beyond generative AI, Singapore is assessing the potential of agentic AI, a category of AI systems capable of autonomous decision-making and goal-oriented actions. The technology is being explored for its ability to adapt to changing environments, support complex decision-making processes, and improve coordination across healthcare operations.
The country has expanded its healthcare AI ecosystem through platforms such as AimSG, an open and vendor-neutral platform that enables hospitals and primary care providers to access and deploy medical imaging AI models. Another initiative, HEALIX, is a cloud-based platform launched last year that allows users to securely conduct analytics projects and access healthcare datasets for AI model development.
The latest efforts underscore Singapore’s ongoing investment in AI-driven healthcare innovation, with a growing emphasis on both generative and autonomous AI applications.
Stay tuned for more such updates on Digital Health News
